Keryx Biopharmaceuticals Inc. is recalling nearly 60,000 bottles of Auryxia (ferric citrate) tablets, 210 mg, because they were not manufactured in accordance with the approved manufacturing process.
Keryx Biopharmaceuticals Inc. is recalling nearly 60,000 bottles of Auryxia (ferric citrate) tablets, 210 mg, because they were not manufactured in accordance with the approved manufacturing process.
Keryx Biopharmaceuticals Inc. is...